6 The phosphodiesterase-five inhibitor sildenafil is certified for PAH in FC I–IV in the United states and FC II–III in Europe. Endothelin receptor antagonists (ERAs) like bosentan, sitaxentan and ambrisentan are oral therapies certified to be used in PAH. As no oral agent has demonstrated superiority there remains debate regarding https://tracleer93825.dailyblogzz.com/26507526/a-simple-key-for-tracleer-unveiled